9/23/2020 - Part 2
On August, 11 2020 Medtronic Diabetes announced its plans to acquire Companion Medical, makers of the InPen, the only FDA cleared smart insulin pen. Medtronic tasked us to collect questions from the Diabetes Community for Julie Foster, so that’s what we did. Since the acquisition has now officially closed, this episode is part 2 of a 2 part series. If you haven’t listened to part 1, check out Episode 159 of Diabetics Doing Things with Sean Salmon
Disclaimer: Rob Howe is a paid consultant of Medtronic Diabetes, this podcast was made possible by Medtronic but Rob’s thoughts and opinions are his own.
In this episode, Rob and Julie discuss:
Julie’s career with Medtronic (30+ years) and her new role as the VP of Customer Experience at Medtronic Diabetes
Julie’s excitement to integrate the InPen into the Medtronic suite of products
Why it’s important for Medtronic to meet patients where they are in their Diabetes journey
Medtronic’s planned integration for the InPen and what InPen customers can expect to hear from Medtronic
A question from the community, regarding affordable diabetes treatment options and how this acquisition helps with that.
Medtronic’s iPort and integration with the InPen
A question from the community on upcoming news about Bluetooth integration for Medtronic pumps